Abstract
The inner milieu of the central nervous system (CNS) is closely regulated by the blood-brain barrier (BBB). By its unique properties, the BBB restricts the entrance of blood-borne large and hydrophilic compounds into the brain, but also tightly controls cellular entry and the supply of nutrients to the brain. In this chapter, we will address the latest advances in both the cellular and molecular biology of this specialized structure, and discuss its functional characteristics and molecular organization in glioma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonetti D.A., Barber A.J., Hollinger L.A., Wolpert E.B., Gardner T.W. 1999. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J. Biol. Chem. 274:23,463–23,467.
Angelov D.N., Krebs C., Walther M., Martinez-Portillo F.J., Gunkel A., Lay C.H., et al. 1998. Altered expression of immune-related antigens by neuronophages does not improve neuronal survival after severe lesion of the facial nerve in rats. Glia 24:155–171.
Avgeropoulos N.G., Batchelor T.T. 1999. New treatment strategies for malignant glioma. The Oncologist 4:209–224.
Aurrand-Lions M., Johnson-Leger C., Wong C., Du Pasquier L., Imhof B.A. 2001. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 98:3699–3707.
Ayalon O., Sabanai H., Lampugnani M.G., Dejana E., Geiger B. 1994. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J. Cell Biol. 126: 247–258.
Baranczyk-Kuzma A., Audus K.L. 1987. Characteristics of aminopeptidase activity from bovine brain microvessel endothelium . J. Cereb. Blood Flow Metab. 7:801–805.
Bazzoni G., Martinez-Estrada O.M., Orsenigo F., Cordenonsi M., Citi S., Dejana E. 2000. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J. Biol. Chem. 275:20,520–20,526.
Bertossi M., Virgintino D., Maiorano E., Occhiogrosso M., Roncali L. 1997. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct. Pathol. 21: 41–49.
Behzadian M.A., Wang X.L., Windsor L.J., Ghaly N., Caldwell R.B. 2001. TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest. Ophthalmol. Vis. Sci. 42:853–859.
Betz A.L., Goldstein G.W. 1978. Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science 202:225–227.
Bradbury M.W. 1985. The blood-brain barrier. Transport across the cerebral endothelium. Circ. Res. 57:213–222.
Brat D.J., Van Meir E.G. 2001. Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am. J. Pathol. 158:1145–1160.
Broadwell R.D., Salcman M. 1981. Expanding the definition of the blood-brain barrier to protein. Proc. Natl. Acad. Sci. USA 78:7820–7824.
Brown R.C., Davis T.P. 2002. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke 33:1706–1711.
Buckley C.D., Doyonnas R., Newton J.P., Blystone S.D., Brown E.J., Watt S.M., Simmons D.L. 1996. Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109: 437–445.
Butt A.M., Jones H.C., Abbott N.J. 1990. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol. 429:47–62.
Chaudhry I.H., O’Donovan D.G., Brenchley P.E., Reid H., Roberts I.H. 2001. Vascular endothelial growth factor expression correlates with tumor grade and vascularity in gliomas. Histopathology 39: 409–415.
Citi S., Sabanay H., Kendrick J.J., Geiger B. 1989. Cingulin: characterization and localization. J. Cell Sci. 93:107–122.
Colombo T., Zucchetti M., D’Incalci M. 1994. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats. J. Pharmacol. Exp. Ther. 269:22–27.
Corada M., Mariotti M., Thurston G., Smith K., Kunkel R., Brockhaus M., et al. 1999. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. USA 96:9815–9820.
Cordon-Cardo C., O’Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., Bertino J.R. 1989. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 86:695–698.
Criscuolo G.R., Lelkes P.I., Rotrosen D., Oldfield E.H. 1989. Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J. Neurosurg. 71:884–891.
Dai. C., Celestino J.C., Okada Y., Louis D.N., Fuller G.N., Holland E.C. 2001. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15:1913–1925.
Davson H., Oldendorf W.H. 1967. Symposium on membrane transport. Transport in the central nervous system. Proc. R. Soc. Med. 60:326–329.
Dean R.L., Emerich D.F., Hasler B.P., Bartus R.T. 1999. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone. Neuro-oncol. 1:268–274.
Dejana E., Corada M., Lampugnani M.G. 1995. Endothelial cell-to-cell junctions. FASEB J. 9:910–918.
Del Sole A., Falini A., Ravasi L., Ottobrini D., De Marchis D., Bombardieri E., Lucignani G. 2001. Anatomical and biochemical investigation of primary brain tumours. Eur. J. Nucl. Med. 28: 1851–1872.
Dempsey E.W., Wislocki G.B. 1955. An electron microscopic study of the blood-brain barrier in the rat, employing silver nitrate as a vital stain. J. Biophys. Biochem. Cytol. 1:245–256.
Denker B.M., Saha C., Khawaja S., Nigam S.K. 1996. Involvement of a heterotrimeric G protein alpha subunit in tight junction biogenesis. J. Biol. Chem. 271:25,750–25,753.
De Vries H.E., Kuiper J., de Boer A.G., van Berkel T.J.C., Breimer D.D. 1997. The blood-brain barrier in neuroinflammatory diseases (review). Pharm. Reviews 49:143–155.
De Vries H.E., Blom-Roosemalen M.C., van Oosten M., de Boer A.G., van Berkel T.J.C., Breimer D.D., Kuiper J. 1996. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64:37–43.
Doolittle N.D., Miner M.E., Hall W.A., Siegal T., Jerome E., Osztie E., et al. 2000. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 88:637–647.
Drion N., Lemaire M., Lefauconnier J.M., Scherrmann J.M. 1996. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. J. Neurochem. 67:1688–1693.
Dunn I.F., Heese O., Black P.M. 2000. Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J. Neurooncol. 50:121–137.
Ehrlich P. 1885. Das Suaerstoffbeduerfnis des Organismus: eine farbenanalystische studie. Hirschwald, Berlin.
Esiri M.M. 1990. Immunological and neuropathological significance of the Virchow-Robin space. J. Neurol. Sci. 100:3–8.
Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W. 1998. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111:1853–1865.
Fabel K., Dietrich J., Hau P., Wismeth C., Winner B., Przywara S., et al. 2001. Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 92:1936–1942.
Fanning A.S., Jameson B.J., Jesaitis L.A., Anderson J.M. 1998. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 273: 29,745–29,753.
Floris S., Ruuls S.R., Wierinckx A., van der Pol S.M.A., Dopp E., van der Meide P.H., et al. 2002. Interferon-beta directly influences monocyte infiltration into the central nervous system. J. Neuroimmunol. 127:69–79.
Fuller G.N., Hess K.R., Rhee C.H., Yung W.K., Sawaya R.A., Bruner J.M., Zhang W. 2002. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol. 12:108–116.
Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. 1998. Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141: 1539–1550.
Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S. 1993. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123:1777–1788.
Gloor S.M., Wachtel M., Bolliger M.F., Ishihara H., Landmann R., Frei K. 2001. Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Rev. 36:258–264.
Goldmann E.E. 1909. Die aussere and innere Sekretion des gesundes und kranken Organismus im Lichte der vitalen Farbung. Beitr. Klin. Chir. 64:192–265.
Goldstein G.W. 1988. Endothelial cell-astrocyte interactions. A cellular model of the blood-brain barrier. Ann. N. Y. Acad. Sci. 529:31–39.
Gow A., Southwood C.M., Li J.S., Pariali M., Riordan G.P., Brodie S.E., et al. 1999. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99:649–659
Graeber M.B., Streit W.J., Kreutzberg G.W. 1989. Identity of ED2-positive perivascular cells in rat brain. J. Neurosci. Res. 22:103–106.
Graesser D., Solowiej A., Bruckner M., Osterweil E., Juedes A., Davis S., et al. 2002. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109:383–392.
Gross P.M. 1992. Circumventricular organ capillaries. Prog. Brain Res. 91:219–233.
Gumbiner B., Lowenkopf T., Apatira D. 1991. Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc. Natl. Acad. Sci. USA 88:3460–3464.
Guo D., Jia Q., Song H.Y., Warren R.S., Donner D.B. 1995. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270:6729–6733.
Hall A. 1999. RhoGTPases and the actin cytoskeleton. Science 279:509–514.
Hardebo J.E., Kahrstrom J. 1985. Endothelial negative surface charge areas and blood-brain barrier function. Acta Physiol. Scand. 125:495–499.
Haskins J., Gu L., Wittchen E.S., Hibbard J., Stevenson B.R. 1998. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J. Cell Biol. 141: 199–208.
Hickey W.F., Kimura H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290–292.
Hirano H., Lopes M.B., Laws E.R. Jr, Asakura T., Goto M., Carpenter J.E., et al. 1999. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas. Neurooncol. 1:109–119.
Hirase T., Staddon J.M., Saitou M., Ando A.Y., Itoh M., Furuse M., et al. 1997. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110:1603–1613.
Hirase T., Kawashima S., Wong E.Y., Ueyama T., Rikitake Y., Tsukita S., et al. 2001. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and-independent mechanisms. J. Biol. Chem. 276:10,423–10,431.
Huber J.D., Egleton R.D., Davis T.P. 2001. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24:719–725.
Huwyler J., Wu D., Pardridge W.M. 1996. Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. USA 93:14,164–14,169.
Jucker M., Tian M., Ingram D.K. 1996. Laminins in the adult and aged brain. Mol. Chem. Neuropathol. 28:209–218.
Kalaria R.N., Harik S.I. 1987. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat. J. Neurochem. 49:1589–1594.
Kjellman C., Olofsson S.P., Hansson O., Von Schantz T., Lindvall M., Nilsson I., et al. 2000. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int. J. Cancer 89:251–258.
Kida S., Steart P.V., Zhang E.T., Weller R.O. 1993. Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol (Berl) 85:646–652.
Klopman G., Shi L.M., Ramu A. 1997. Quantitative structure-activity relationship of multidrug resistance reversal agents. Mol. Pharmacol. 52:323–333.
Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C, et al. 2002. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61:215–225
Kniesel U., Wolburg H. 2000. Tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 20:57–76.
Lampugnani M.G., Dejana E. 1997. Interendothelial junctions: structure, signaling and functional roles. Curr. Opin. Cell Biol. 9:674–682.
Lassmann H., Zimprich F., Vass K., Hickey W.F. 1991. Microglial cells are a component of the perivascular glia limitans. J. Neurosci. Res. 28:236–243.
Legget D.A.C., Miles K.A., Kelley B.B. 1999. Blood-brain barrier and blood-volume imaging of cerebral glioma using functional CT: a pictorial view. Eur. J. Radiol. 30:185–190.
Li J.Y., Boado R.J., Pardridge W.M. 2001. Blood-brain barrier genomics. J. Cereb. Blood Flow Metab. 21:61–68.
Liebner S., Fischmann A., Rascher G., Duffner F., Grote E.H., Kalbacher H., et al. 2000. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 100:323–331.
Ljubimova J.Y., Lakhter A.J., Loksh A., Yong W.H., Riedinger M.S., Miner J.H., et al. 2001. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res. 61:5601–5610.
Machein M.R., Kullmer J., Fiebich B.L., Plate K.H., Warnke P.C. 1999. Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors. Neurosurgery 44: 732–740.
Martìn-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., et al. 1998. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142:117–127.
Mato M., Ookawara S., Saito-Taki T. 1996. Serological determinants of fluorescent granular perithelial cells along small cerebral blood vessels in rodent. Acta Neuropathol (Berl). 72:117–123.
Mitic L.L., Anderson J.M. 1998. Molecular architecture of the tight junction. Annu. Rev. Physiol. 60:121–142.
Miyagami M., Tazoe M.,. Nakamura S. 1998. Expression of vascular endothelial growth factor and p53 protein in association with neovascularization in human malignant gliomas. Brain Tumor Pathol. 15:95–100.
Miyagi N., Kato S., Terasaki M., Shigemori M., Morimatsu M. 1998. Fibroblast growth factor-2 and-9 regulate proliferation and production of matrix metalloproteinases in human gliomas. Int. J. Oncol. 12: 1085–1090.
Monaghan M., Mulligan K.A., Gillespie H., Trimble A., Winter P., Johnston P.G., et al. 2000. Epidermal growth factor up-regulates CD44-dependent astrocytmoa invasion in vitro. J. Pathol. 192:519–525.
Morita K., Furuse M., Fujimoto K., Tsukita S. 1999a. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA 96:511–516.
Morita K., Sasaki H., Furuse M., Tsukita S. 1999b. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147:185–194.
Muleris M., Almeida A., Dutrillaux A.M., Pruchon E., Vega F., Delattre J.Y., et al. 1994. Oncogene amplification in human gliomas: a molecular cytogenetic analysis. Oncogene 9:2717–2722.
Muller W.A., Berman M.E., Newman P.J., DeLisser H.M., Albelda S.M. 1992. A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J. Exp. Med. 175:1401–1404.
Nasdala I., Wolburg-Buchholz K., Wolburg H., Kuhn A., Ebnet K., Brachtendorf G., et al. 2002. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J. Biol. Chem. 277:16,294–16,303.
Ookawara S., Mitsuhashi U., Suminaga Y., Mato M. 1996. Study on distribution of pericyte and fluorescent granular perithelial (FGP) cell in the transitional region between arteriole and capillary in rat cerebral cortex. Anat Rec. 244:257–264.
Papadopoulos M.C., Saadoun S., Woodrow C.J., Davies D.C., Costa-Martins P., Moss R.F., et al. 2001. Occludin expression in microvessels of neoplastic and non-neoplastic human brain. Neuropathol. Appl. Neurobiol. 27:384–395.
Pardridge W.M. 1986. Blood-brain transport of nutrients. Fed. Proc. 45:2047–2049.
Pardridge W.M. 2002. Targeting neurotherapeutic agents through the blood-brain barrier. Arch. Neurol. 59:35–40.
Planchenault T., Costa S., Fages C., Riche D., Charriere-Bertrand C., Perzelova A., et al. 2001. Differential expression of laminin and fibronectin and of their related metalloproteinases in human glioma cell lines: relation to invasion. Neurosci Lett 299:140–144.
Platten M., Wick W., Weller M. 2001. Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc. Res. Tech. 52:401–410.
Polfliet M.M.,. Zwijnenburg P.J., van Furth A.M., van der Poll T., Dopp E.A., Renardel de Lavalette C., et al. 2001. Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J. Immunol. 167:4644–4650.
Polfliet M.M., van de Veerdonk F., Dopp E.A., van Kesteren-Hendrikx E.M., van Rooijen N., et al. 2002. The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis J. Neuroimmunol. 122:1–8.
Prat A., Biernacki K., Wosik K., Antel J.P. 2001. Glial cell influence on the human blood-brain barrier. Glia 36:145–155.
Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. 1991. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 87:1360–1366.
Radford I.R. 2002. Imatinib. Novartis. Curr. Opin. Investig. Drugs 3:492–499.
Raithatha S.A., Muzik H., Rewcastle N.B., Johnston R.N., Edwards D.R., Forsyth P.A. 2000. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neurooncol. 2:145–150.
Raub T.J. 1996. Signal transduction and glial cell modulation of cultured brain microvessel endothelial cell tight junctions. Am. J. Physiol. 271:C495–C503.
Robinson P.J., Rapoport S.I. 1986. Kinetics of protein binding determine rates of uptake of drugs by brain. Am. J. Physiol. 251:R1212–1220.
Reese T.S., Feder N., Brightman M.W. 1971. Electron microscopic study of the blood-brain and blood-cerebrospinal fluid barriers with microperoxidase. J. Neuropathol. Exp. Neurol. 30:137–138.
Reese T.S., Karnovsky M.J. 1967. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34:207–217.
Roopraai H.K.,. Van Meter T., Rucklidge G.J., Hudson L., Everal L.P., Pilkington G.J. 1998. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int J Oncol. 13:1153–1157.
Rousselle C., Clair P., Lefauconnier J.M., Kaczorek M., Scherrmann J.M., Temsamani J. 2000. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57:679–686.
Rubin L.L. 1992. Endothelial cells: adhesion and tight junctions. Curr. Opin. Cell Biol. 4: 830–833.
Saha C., Nigam S.K., Denker B.M. 1998. Involvement of Galphai2 in the maintenance and biogenesis of epithelial cell tight junctions. J. Biol. Chem. 273:21,629–21,633.
Saitou M, Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., et al. 2000. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell 11:4131–4142.
Sawada T., Kato Y., Kobayashi M., Takekekawa Y. 2000. Immunohistochemical study of tight junction-related protein in neovasculature in astrocytic tumor. Brain Tumor Pathol. 17:1–6.
Schenkel A.R., Mamdouh Z., Chen X., Liebman R.M., Muller W.A. 2002. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3:143–150
Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. 1995. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest 96:1698–1705.
Schinkel A.H., Mol C.A., Wagenaar E., van Deemter L., Smit J.J., Borst P. 1995b. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur. J. Cancer 31A:1295–1298.
Schulze C., Firth J.A. 1993. Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. J. Cell Sci. 104:773–782.
Shusta E.V.,. Boado R.J., Mathern G.W., Pardridge W.M. 2002. Vascular genomics of the human brain. J. Cereb. Blood Flow Metab. 22:245–252.
Simionescu M., Simionescu N. 1986. Functions of the endothelial cell surface. Ann. Rev. Physiol. 48:279–293.
Sixt M., Engelhardt B., Pausch F., Hallmann R., Wendler O., Sorokin L.M. 2001. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J. Cell Biol. 153:933–946.
Sobel R.A. 1998. The extracellular matrix in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 57:205–217
Sobel R.A. 2001. The extracellular matrix in multiple sclerosis: an update. Braz. J. Med. Biol. Res. 34:603–609.
Staddon J.M., Rubin L.L. 1996. Cell adhesion, cell junctions and the blood-brain barrier. Curr. Opin. Neurobiol. 6:622–627.
Staddon J.M., Herrenknecht K., Smales C., Rubin L.L. 1995. Evidence that tyrosine phosphorylation may increase tight junction permeability. J. Cell Sci. 108:609–619.
Stevenson B.R., Keon B.H. 1998. The tight junction: morphology to molecules. Ann. Rev. Cell Dev. Biol. 14:89–109.
Stewart P.A., Wiley M.J. 1981. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail—chick transplantation chimeras. Dev. Biol. 84:183–192.
Sun Q.H., DeLisser H.M., Zukowski M.M., Paddock C., Albelda S.M., Newman P.J. 1996. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J. Biol. Chem. 271:11,090–11,098.
Thomas K.A. 1996. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271:603–606.
Tian M., Hagg T., Denisova N., Knusel B., Engvall E., Jucker M. 1997. Laminin-alpha2 chain-like antigens in CNS dendritic spines. Brain Res. 764:28–38.
Tian Y.C., Phillips A.O. 2002. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am. J. Pathol. 160:1619–1628.
Tsukita S., Furuse M. 1999. Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol. 9:268–273.
Van der Valk P., Lindeman J., Kamphorst W. 1997. Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma? Ann.Oncol. 8:1023–1029.
Van der Goes A., Wouters D., van der Pol S.M.A., Huizinga R., Ronken E., Adamson P., et al. 2001. Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J. 15:1852–1854.
Van der Sanden B.P., Rozijn T.H., Rijken P.F., Peters H.P., Heerschap A., van der Kogel A.J., Bovee W.M. 2000. Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake. J. Cereb. Blood Flow Metab. 20:861–870.
Wang W.,. Dentler W.L., Borchardt R.T. 2001. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am. J. Physiol. Heart Circ. Physiol. 280:434–440.
Wick W., Grimmel C., Wild-Bode C., Platten M., Arpin M., Weller M. 2001. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. J. Neurosci. 21:3360–3368.
Wild-Bode C., Weller M., Wick W. 2001. Molecular determinants of glioma cell migration and invasion. J. Neurosurg. 94:978–984.
Wolburg H., Neuhaus J., Kniesel U., Krauss B., Schmid E.M, Ocalan M., et al. 1994. Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J. Cell Sci. 107:1347–1357.
Yao Y.,. Kubota T., Sato K., Kitai R., Takeuchi H., Arishima H. 2001. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours. Acta Neurochir. (Wien) 143:159–166.
Yong V.W.,. Krekoski C.A., Forsyth P.A., Bell R., Edwards D.R. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21:75–80.
Yoshida D., Noha M., Watanabe K., Sugisaki Y., Teramoto A. 2002. SI-27, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity: detection with a variable-pressure scanning electron microscope. Neurosurgery 50:578–586.
Zhong Y., Saitoh T., Minase T., Sawada N., Enomoto K., Mori M. 1993. Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2. J. Cell Biol. 120:477–483.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
de Vries, H.E., Montagne, L., Dijkstra, C.D., van der Valk, P. (2005). Molecular and Cellular Biology of the Blood-Brain Barrier and Its Characteristics in Brain Tumors. In: Ali-Osman, F. (eds) Brain Tumors. Contemporary Cancer Research. Humana Press. https://doi.org/10.1385/1-59259-843-9:157
Download citation
DOI: https://doi.org/10.1385/1-59259-843-9:157
Publisher Name: Humana Press
Print ISBN: 978-1-58829-042-7
Online ISBN: 978-1-59259-843-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)